CARE:TSX-Dialogue Health Technologies Inc (CAD)

COMMON STOCK | Health Information Services | TSX

Last Closing Price

CAD 3.60

Change

-0.11 (-2.96)%

Market Cap

CAD 0.24B

Volume

0.04M

Avg Analyst Target

CAD 8.64 (+140.13%)

Avg User Target

CAD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


CARE Stock Forecast & Price:
Based on the Dialogue Health Technologies Inc stock forecasts from 5 analysts, the average analyst target price for Dialogue Health Technologies Inc is CAD 8.64 over the next 12 months. Dialogue Health Technologies Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Dialogue Health Technologies Inc is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Dialogue Health Technologies Inc’s stock price was CAD 3.60. Dialogue Health Technologies Inc’s stock price has changed by -13.04% over the past week, +29.96% over the past month and -64.04% over the last year.

About Dialogue Health Technologies Inc (CARE:CA:TSX)

Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada Germany, and Australia. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, p ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-08-12 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
KSI:CA Kneat.com Inc

+0.08 (+2.62%)

CAD0.26B N/A -51.96
VHI:CA Vitalhub Corp

+0.05 (+1.87%)

CAD0.12B N/A 30.86
MBCN:CA MindBeacon Holdings Inc

N/A

CAD0.08B N/A N/A

ETFs Containing CARE:CA

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Health Information Services)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -50.62% 33% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -50.62% 33% F 4% F
Trailing 12 Months  
Capital Gain -62.69% 33% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -62.69% 33% F 4% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -18.47% 33% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -18.47% 33% F 2% F
Risk Return Profile  
Volatility (Standard Deviation) 30.97% 100% A+ 28% F
Risk Adjusted Return -59.65% 33% F 5% F
Market Capitalization 0.24B 67% D+ 46% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Health Information Services)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 2.22 67% D+ 31% F
Price / Cash Flow Ratio -10.19 67% D+ 85% B
EV/EBITDA -6.45 67% D+ 83% B
Management Effectiveness  
Return on Equity -24.29% 67% D+ 14% F
Return on Invested Capital -57.16% 33% F 6% F
Return on Assets -13.17% 33% F 9% F
Debt to Equity Ratio 0.90% 100% A+ 92% A-
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 6.81 33% F 30% F
Short Percent 0.18% 50% F 71% C-
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.